RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)

A blocking anti-APRIL antibody decreases autoantibody serum levels. by Bertrand Huard (111620)

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

Rab27A deficiency caused decreased amylase release from isolated acini. by Yanan Hou (736195)

U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

“…<b><i>C</i></b>. The inoculation of U87MG gal-3 shRNA cells in the flank of nuce mice (n = 5) demonstrated a decrease in tumor size and growth compared to the U87MG scramble shRNA (n = 6). …”

<i>Il-17c</i> deletion decreases the expression of inflammatory cytokines. by Giovanna Vella (6413774)

Fig 5 - by Te-Hsing Hsu (16973374)

Percentage of patients with hypokalemia (potassium <3.5 mEq/L), hyperkalemia (potassium >5.5 mEq/L) and hyperphosphatemia (phosphate >5.5 mg/dL) before (black/gray columns) and aft... by Daniela Peruzzo (11570702)

Full-length PRR expression increases and sPRR secretion decreases in the absence of PACE4 in mouse. by Amro H. Mohammad (15081540)

Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)

Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Effects of H5 (20 and 40 mg/kg, p.o.), and diazepam (2.5 mg/kg, i.p.) in the Rota-rod test in mice. by Maria Alice Miranda Bezerra Medeiros (11752002)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Loss of Sidt2 decreased insulin granule exocytosis. by Jialin Gao (420257)

S5 File - by Wenxin Ye (14392899)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”

Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2. by Shaija Samuel (341436)

“…Tumor weight was significantly lower in NRP-2-siRNA-DOPC treated mice (mean, 160 mg) compared to cntr siRNA DOPC-treated mice (mean, 459 mg; *<i>p</i> = 0.01). …”